Oncostellae
PrivateLast Round
Grant
Jul 1, 2025
Est. Valuation
$20.31M
Total Funding Raised
$3.22M
Company Overview
Oncostellae operates in Healthcare & Life Sciences and is based in Santiago de Compostela. Its latest recorded funding round was a VC Round in March 2024.
Oncostellae is a biotechnology company that develops small-molecule drugs for the treatment of oncology and inflammatory/autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncostellae Comparables
Compare Oncostellae with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ability Pharmaceuticals | 85% | |
| Leukos Biotech | 84% | |
| Palobiofarma S.L. | 83% |
For institutional investors. Book with your work email.
Oncostellae Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| VC Round | Mar 18, 2024 | ||||
| VC Round | Jul 6, 2023 | ||||
| VC Round | Nov 22, 2022 | ||||
| Debt | Dec 22, 2020 | ||||
VC Round | Jun 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oncostellae Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noso Capital | VC Round |
| CDTI Innvierte | VC Round |
| Inveready | VC Round, Seed, Series A |
| Unirisco Galicia | VC Round, Series A |
| Empresa Nacional de Innovación | Debt |
| Center for Technological Development and Innovation | VC Round, Grant |
| Xesgalicia | VC Round, Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 4132% MoM, from 38 to 1.6K.
- Mar 18, 2024
$540K raised from biotechsmartcapital, Noso Capital, and Center for Technological Development and Innovation.
For institutional investors. Book with your work email.
Oncostellae Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncostellae's valuation, stock price, and market status.
Is Oncostellae a public or private company?
Oncostellae is a private company.
What is the current stock price of Oncostellae?
Oncostellae is a private company, so its shares have no public market price. Caplight tracks Oncostellae's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncostellae worth (valuation)?
Oncostellae's valuation is estimated at $20.3M based on funding round data.
Can I buy Oncostellae stock?
Oncostellae shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncostellae's last funding round?
Oncostellae's most recent funding round was Grant on July 1, 2025.
Who are the main investors in Oncostellae?
Key investors in Oncostellae include Noso Capital.
Will Oncostellae IPO soon?
No public IPO plans have been announced for Oncostellae.
How can I track Oncostellae secondary market activity?
Caplight tracks bids, offers, and trades in Oncostellae's shares on secondary markets.